Innovation in Patient Access
In the U.S., The Roche Foundation was established in 1947. In 1963, Roche became the first company in the pharmaceutical industry to introduce a formal Indigent Patient Program to provide the cancer drug fluorouracil free to people who couldn't afford it. The program was extended to Roche's full product line in 1967.
Patient Access Programs in the U.S.
Corporate Citizenship
Our commitment to corporate citizenship includes:
- A respect for the individual, both within and outside our organization
- Meeting high standards of performance in business practices, policies, ethics and results
- A wide range of health, education and social service programs and activities
- Contributions to disaster-relief efforts
- Views, policies and actions toward the environment
Contributing to Our Communities
In areas surrounding key Roche facilities, our citizenship efforts are guided by our desire to understand the needs of our extended communities. As we become familiar with the social, educational, medical and other needs that contribute to a "healthy" community, it's our aim to become a trusted and valued partner in bringing our capabilities to bear in addressing those needs. Our philanthropic activities may take the form of financial support, in-kind giving, intellectual expertise or volunteerism.
Access more information on site-specific community programs in the Locations section.
- © 2013 Hoffmann-La Roche Inc.
-
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.